Ebola: Japan Offers Drug, Nigerian Patient To Be Discharged

Fresh hope appears in the horizon for Ebola  patients as Japan on Monday expressed its readiness to provide its anti-influenza drug as treatment for the deadly virus.

Japan’s Chief Cabinet Secretary, Yoshihide Suga, made the offer hours after a group of scientist in the United Kingdom said it had discovered that the largest outbreak of the   Ebola Virus Disease was caused by an infected fruit bat that bit a toddler.



Briefing   journalists in Tokyo on Monday, Suga said Japan   was ready to offer the drug, Favipiravir, which was developed by Toyama Chemical, a subsidiary of Fujifilm, any time   the World Health Organisation requested it.

Approved by the Japanese health ministry in March, Favipiravir is a tablet developed   for the treatment of novel and re-emerging influenza viruses.